Progressive pulmonary fibrosis is not a diagnosis so much as a disease behavior and a clinical phenotype, says Anna-Maria ...
The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...
Dr Marco Zuin shares key guideline recommendations for managing pulmonary embolism according to international standards.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback